CVE-2018-14787
Last modified
CVE-2018-14787 is a high-severity vulnerability rated 7.8/10 on the CVSS scale. In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executables where authenticated users have write permissions, and could then execute arbitrary code with local administrative permissions.. EPSS estimates a 0.39% chance of exploitation in the next 30 days.
Description
In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executables where authenticated users have write permissions, and could then execute arbitrary code with local administrative permissions.
Metrics
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Philips | Intellispace Cardiovascular | <= 3.1 |
| Philips | Xcelera | <= 4.1 |
References
- https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01Third Party Advisory, US Government Resource
- https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01Third Party Advisory, US Government Resource
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2018-14787?
How severe is CVE-2018-14787?
How do I fix CVE-2018-14787?
Are you affected by CVE-2018-14787?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST
